Cyber Daily Report

News

Home News

Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

  • Nurix Therapeutics, Inc.--GlobeNewswire
  • published date: 2025-10-09 20:01:00 UTC

Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented......

Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical data at EADV 2025 for GS-6791 (NX-0479),… [+21496 chars]

Most Popular

Autonomous AI Hacking and the Future of Cybersecurity

  • None -- securityboulevard.com
  • Published date: 2025-10-10 00:00:00 UTC

The Psychology of Security: Why Users Resist Better Authentication

  • None -- securityboulevard.com
  • Published date: 2025-10-10 00:00:00 UTC

What is CAA? Understanding Certificate Authority Authorization

  • None -- securityboulevard.com
  • Published date: 2025-10-10 00:00:00 UTC

Red Pilling of Politics – Court Strikes Down California Law on Political Deepfakes

  • Mark Rasch -- securityboulevard.com
  • Published date: 2025-10-10 00:00:00 UTC

Shadow AI: Agentic Access and the New Frontier of Data Risk

  • Aditya Ramesh -- securityboulevard.com
  • Published date: 2025-10-10 00:00:00 UTC